Xeljanz and Joint pain - a phase IV clinical study of FDA data
Summary:
Joint pain is found among people who take Xeljanz, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Xeljanz and have Joint pain. It is created by eHealthMe based on reports of 222,287 people who have side effects when taking Xeljanz from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
222,287 people reported to have side effects when taking Xeljanz.
Among them, 25,292 people (11.38%) have Joint pain.
What is Xeljanz?
Xeljanz has active ingredients of tofacitinib citrate. It is often used in rheumatoid arthritis. eHealthMe is studying from 222,435 Xeljanz users for its effectiveness, alternative drugs and more.
What is Joint pain?
Joint pain is found to be associated with 4,882 drugs and 4,988 conditions by eHealthMe.
Number of Xeljanz and Joint pain reports submitted per year:
Time on Xeljanz when people have Joint pain *:
Gender of people who have Joint pain when taking Xeljanz*:
Age of people who have Joint pain when taking Xeljanz *:
Common drugs people take besides Xeljanz *:
Common side effects people have besides Joint pain *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Xeljanz and have Joint pain?
Check whether Joint pain is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Joint pain and when was it recovered:
Expand to all the drugs that have ingredients of tofacitinib citrate:
- Joint pain and drugs with ingredients of tofacitinib citrate (21,279 reports)
Alternative drugs to, pros and cons of Xeljanz:
- Xeljanz (222,435 reports)
Common Xeljanz side effects:
- Drug ineffective: 48,562 reports
- Pain: 26,984 reports
- Joint pain: 25,292 reports
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints): 20,971 reports
- Fatigue (feeling of tiredness): 16,775 reports
- Headache (pain in head): 16,267 reports
- Joint swelling: 15,442 reports
- Malaise (a feeling of general discomfort or uneasiness): 13,828 reports
- Diarrhea: 12,636 reports
Browse all side effects of Xeljanz:
a b c d e f g h i j k l m n o p q r s t u v w x y zJoint pain treatments and more:
- Joint pain (506,133 reports)
COVID vaccines that are related to Joint pain:
- Joint pain in Moderna COVID Vaccine
- Joint pain in Pfizer BioNTech Covid Vaccine
- Joint pain in Johnson and Johnson Covid Vaccine
Common drugs associated with Joint pain:
- Enbrel: 49,616 reports
- Humira: 47,464 reports
- Methotrexate: 45,719 reports
- Prednisone: 38,003 reports
- Xeljanz: 25,292 reports
- Actemra: 16,945 reports
- Orencia: 16,537 reports
- Cosentyx: 16,485 reports
- Aspirin: 15,754 reports
- Leflunomide: 14,380 reports
All the drugs that are associated with Joint pain:
- Joint pain (4,882 drugs)
Common conditions associated with Joint pain:
- Rheumatoid arthritis: 80,403 reports
- Osteoporosis: 19,578 reports
- Psoriasis: 15,985 reports
- High blood pressure: 15,849 reports
- Crohn's disease: 15,813 reports
- High blood cholesterol: 14,883 reports
- Pain: 14,528 reports
All the conditions that are associated with Joint pain:
- Joint pain (4,988 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on tofacitinib citrate (the active ingredients of Xeljanz) and Xeljanz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Norethindrone Acetate and Fluoxetine drug interaction - 7 seconds ago
- How effective is Azelastine for Allergies? - 8 seconds ago
- Premarin and Urinary Bladder Haemorrhage - 8 seconds ago
- Amoxicillin and Crystal Nephropathy - 9 seconds ago
- Furosemide and Parkinsonism Aggravated - 10 seconds ago
- Klor-Con and Psorcon drug interaction - 12 seconds ago
- Adderall and Renal Function Test Abnormal - 13 seconds ago
- Hiv Infection and Pvt - 17 seconds ago
- Amitriptyline Hydrochloride and Anticonvulsant Drug Level Increased - 17 seconds ago
- Hydrea and Toxic Encephalopathy - 20 seconds ago